← Leaderboards
Sherry Chow
University Of Arizona
$5,767,484
Attributed
$5,767,484
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.4M · FY2009–22$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$5,767,484 · 2
By mechanism
N01$5,767,484 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Arizona
Same institution · by research overlap
- Eugene W Gerner$5,028,555
- Alison T Stopeck$4,717,705
- Jennifer K. Barton$15,034,989
- Anna R Giuliano$35,098,080
- James Marshall$14,878,530
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsSafetyClinical TrialsNational Cancer InstituteMolecular TargetPreventiveClinically RelevantBiologicalDivision Of Cancer PreventionCancer PreventionMonitorMaintenanceMeetingsPerformanceGuidelinesClinical ChemopreventionInfrastructureContractorData ManagementConduct Clinical TrialsClinical ResearchDrug IndustryLaboratory ExperimentFunding
Grant awards (12)
CORE INFRASTRUCTURE SUPPORT FOR THE CANCER PREVENTION AGENT DEVELOPMENT PROGRAM$242,912
N01 · FY2022 · CA · contact PI
CORE INFRASTRUCTURE SUPPORT FOR THE CANCER PREVENTION AGENT DEVELOPMENT PROGRAM$242,912
N01 · FY2021 · CA · contact PI
CORE INFRASTRUCTURE SUPPORT FOR THE CANCER PREVENTION AGENT DEVELOPMENT PROGRAM$410,751
N01 · FY2020 · CA · contact PI
Topical Therapies for Treatment of Cervical Intraepithelial Neoplasia 2-3$225,296
N01 · FY2020 · CA · contact PI
Clinical Study of Avmacol for Detoxification of Tobacco Carcinogens in Heavy Smokers$44,794
N01 · FY2020 · CA · contact PI
CORE INFRASTRUCTURE SUPPORT FOR THE CANCER PREVENTION AGENT DEVELOPMENT PROGRAM$638,921
N01 · FY2019 · CA · contact PI
Clinical Study of Avmacol for Detoxification of Tobacco Carcinogens in Heavy Smokers$269,250
N01 · FY2019 · CA · contact PI
Topical Therapies for Treatment of Cervical Intraepithelial Neoplasia 2-3$171,153
N01 · FY2018 · CA · contact PI
IGF::OT::IGF Clinical Study of Avmacol for Detoxification of Tobacco Carcinogens in Heavy Smokers$487,895
N01 · FY2017 · CA · contact PI
IGF::OT::IGF Topical Therapies for Treatment of CIN 2-3$405,600
N01 · FY2017 · CA · contact PI
Phase I and II Clinicla Trials of Cancer Prevention Agents$1,196,000
N01 · FY2011 · CA · contact PI
Phase I and II Clinicla Trials of Cancer Prevention Agents$1,432,000
N01 · FY2009 · CA · contact PI